King Bio Recalls Dr. King's SafeCare Rx Odor Freee Due to Microbial Contamination
King Bio Inc. is recalling 23 bottles of Dr. King's SafeCare Rx Odor Freee due to microbial contamination. The product was distributed in the U.S., Canada, and Australia.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA has classified this recall as Class I, which meets the rubric criteria for a Critical severity score (5).
Plain-English summary
King Bio Inc. is recalling 23 bottles of Dr. King's SafeCare Rx Odor Freee, 2 fl. oz. (59 mL), due to microbial contamination. The product is identified by NDC 57955-0130-2 and UPC 357955013020. The specific lot affected is 052516G with an expiration date of 05/19.
The recall covers products distributed nationwide in the United States, as well as in Canada and Australia. The FDA has classified this recall as Class I, indicating a reasonable probability that use of the product may cause serious adverse health consequences or death.
Consumers who have this product should stop using it and contact King Bio Inc. for further instructions or a refund. The manufacturer is located at 3 Westside Drive, Asheville, NC 28806.
The recalled product
- Product
- Dr. King's SafeCare Rx Odor Freee..., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955013020, NDC 57955-0130-2
- Manufacturer
- King Bio Inc.
- Category
- Drug — Topical
- Hazard
- Affected units
- 23
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lots: 052516G Exp. 05/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- ModeratePfizer Recalls Oxecta Tablets Due to Failed Impurity Specifications
FDA (Drugs) · 2015-03-11
- SevereFDA Recalls Ganciclovir Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- CriticalFDA Recalls Respitrol Homeopathic Medicine Due to Microbial Contamination
FDA (Drugs) · 2018-09-19
- SevereFDA Recalls Hydroxocobalamin Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereApothecary Pharma Recalls Tirzepatide Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereGanciclovir Syringes Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12